We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
+16.11%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$42.7B
AUM Growth
+$3.67B
(+9.4%)
Cap. Flow
-$1.56B
Cap. Flow
% of AUM
-3.65%
Top 10 Holdings %
Top 10 Hldgs %
16.5%
Holding
2,714
New
351
Increased
1,025
Reduced
1,076
Closed
234
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$367M |
| 2 |
Johnson & Johnson
JNJ
|
+$294M |
| 3 |
Fortinet
FTNT
|
+$260M |
| 4 |
General Mills
GIS
|
+$220M |
| 5 |
Rivian
RIVN
|
+$218M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$485M |
| 2 |
Tesla
TSLA
|
+$476M |
| 3 |
Advanced Micro Devices
AMD
|
+$417M |
| 4 |
Coca-Cola
KO
|
+$344M |
| 5 |
Pfizer
PFE
|
+$300M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.54% |
| 2 | Consumer Discretionary | 12.61% |
| 3 | Healthcare | 11.89% |
| 4 | Financials | 10.49% |
| 5 | Industrials | 10.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2376
loanDepot
LDI
$542M
| $65.1K | ﹤0.01% |
+18,500
| New | +$34.8K |
|
2377
CytomX Therapeutics
CTMX
$714M
| $63.9K | ﹤0.01% |
41,200
-66,700
| -62% | -$87.7K |
|
2378
Perimeter Solutions
PRM
$6.07B
| $62.6K | ﹤0.01% |
+13,600
| New | +$52.2K |
|
|
CBD
2379
DELISTED
Companhia Brasileira de Distribuicao
CBD
| $61.8K | ﹤0.01% |
77,289
-19,411
| -20% | -$13.7K |
|
2380
Gaia
GAIA
$46.8M
| $61.8K | ﹤0.01% |
22,900
-300
| -1% | -$806 |
|
2381
Century Casinos
CNTY
$33.2M
| $61.5K | ﹤0.01% |
12,600
-15,500
| -55% | -$71.6K |
|
|
SOL
2382
DELISTED
Emeren Group
SOL
| $61.2K | ﹤0.01% |
22,400
+1,600
| +8% | +$4.23K |
|
2383
Bionano Genomics
BNGO
$12.2M
| $60.8K | ﹤0.01% |
+536
| New | +$56K |
|
2384
Inovio Pharmaceuticals
INO
$54M
| $59.8K | ﹤0.01% |
9,775
+8,675
| +789% | +$42.8K |
|
2385
Veritone
VERI
$97.6M
| $59.5K | ﹤0.01% |
32,900
-1,200
| -4% | -$2.67K |
|
2386
Sundial Growers
SNDL
$325M
| $58.9K | ﹤0.01% |
35,900
+2,500
| +7% | +$3.76K |
|
2387
GrowGeneration
GRWG
$87.1M
| $58.2K | ﹤0.01% |
23,200
+4,800
| +26% | +$11.8K |
|
2388
Traws Pharma
TRAW
$6.72M
| $58.1K | ﹤0.01% |
3,119
-675
| -18% | -$11.5K |
|
2389
Cardiff Oncology
CRDF
$66.2M
| $58K | ﹤0.01% |
39,200
-1,800
| -4% | -$2.18K |
|
2390
Stoke Therapeutics
STOK
$1.87B
| $57.9K | ﹤0.01% |
11,000
-2,800
| -20% | -$12K |
|
2391
Nerdy
NRDY
$107M
| $55.9K | ﹤0.01% |
+16,300
| New | +$50K |
|
|
ME
2392
DELISTED
23andMe Holding Co
ME
| $55.4K | ﹤0.01% |
+3,030
| New | +$52.4K |
|
|
ELEV
2393
DELISTED
Elevation Oncology
ELEV
| $55.1K | ﹤0.01% |
102,700
+25,900
| +34% | +$13.7K |
|
2394
Karyopharm Therapeutics
KPTI
$159M
| $54.7K | ﹤0.01% |
4,213
+1,866
| +80% | +$25.1K |
|
2395
Aquestive Therapeutics
AQST
$467M
| $54.1K | ﹤0.01% |
26,800
-3,300
| -11% | -$5.83K |
|
2396
Protara Therapeutics
TARA
$227M
| $50.7K | ﹤0.01% |
27,018
-800
| -3% | -$1.18K |
|
2397
Fortuna Silver Mines
FSM
$2.66B
| $50.2K | ﹤0.01% |
+13,000
| New | +$43.5K |
|
2398
Adaptive Biotechnologies
ADPT
$3.85B
| $49K | ﹤0.01% |
+10,000
| New | +$45.6K |
|
2399
Alto Ingredients
ALTO
$358M
| $48.7K | ﹤0.01% |
+18,300
| New | +$58.3K |
|
2400
Latham Group
SWIM
$632M
| $48.7K | ﹤0.01% |
+18,500
| New | +$45.8K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q4 2023 Portfolio in Review
As of Q4 2023, Two Sigma Advisers held 2,714 positions worth $42.7B, up 9.4% from $39B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Two Sigma Advisers withdrew a net $1.56B in Q4 2023, closing 234 positions and reducing 1,076 holdings. Its most notable exit was Palo Alto Networks, an estimated $281M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Two Sigma Advisers opened a new position in Block Inc worth $238M.
- Two Sigma Advisers's largest Q4 2023 buy was Block Inc: 3,076,207 shares worth $238M.
- Two Sigma Advisers added most to Merck in Q4 2023, an estimated $367M increase.
- Two Sigma Advisers's biggest Q4 2023 reduction was Nike, cutting an estimated $485M.
- Two Sigma Advisers fully exited Palo Alto Networks in Q4 2023, selling an estimated $281M.
- Two Sigma Advisers's ten largest holdings make up 16% of its $42.7B portfolio in Q4 2023.
- Two Sigma Advisers opened 351 new positions and closed 234 in Q4 2023.
- Two Sigma Advisers's portfolio value rose 9.4% quarter-over-quarter to $42.7B.
Based on Two Sigma Advisers's 13F filing for Q4 2023, filed 14 Feb 2024.